Real-world data suggest nirogacestat boosts response in desmoid tumor vs standard-of-care treatment, but small cohorts leave ...

Daraxonrasib reduced mortality risk versus chemotherapy in previously treated RAS G12–mutant mPDAC (OS HR 0.40) with fewer discontinuations and delayed pain/QoL deterioration. Perioperative ...

“The results support daraxonrasib as the new standard of care for patients with previously treated metastatic PDAC,” said Brian Wolpin, MD. Daraxonrasib reduced the risk of death by 60% compared with ...

The multicenter ROADS trial was co-led by Jeffrey Weinberg, MD, professor of Neurosurgery, and Thomas H. Beckham, MD, PhD, ...

Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced that results from its Phase ...

Komodo Health claims analyses in first-line CLL showed zanubrutinib associated with lower mortality (adjusted HR 0.75) and improved TTNT (HR 0.89) versus acalabrutinib. In R/R MCL (≥2L), zanubrutinib ...

ABSTRACT: To ensure the safety of “Manten-Kirari”, a non-bitter and trace-rutinosidase variety of Tartary buckwheat, we evaluated its mutagenic activity in a bacterial reverse mutagenicity assay, the ...

The study will assess the ability of Cu-64 SAR-bisPSMA to detect prostate cancer within the pelvic lymph nodes. CLARIFY, a prospective phase 3 trial of Cu-64 SAR-bisPSMA for prostate cancer, is set to ...

Ken Van Haren and Chris Stanley were data scientists at Google and Square, respectively, who found themselves frustrated by how much time they were spending wrangling infrastructure versus doing ...

ABSTRACT: Background and Objective: The aesthetic products’ safety should not be neglected to the detriment of the market. This study aimed to evaluate the mutagenic potential of commercial inks. It ...

Michael J. Morris, MD, discusses the choice between the 2 FDA-approved PSMA-PET imaging agents—and piflufolastat F 18 (18F-DCFPyL; Pylarify) and Gallium 68 PSMA-11 (Ga 68 PSMA-11)—for managing ...